ALBION FINANCIAL GROUP /UT - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 2 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALBION FINANCIAL GROUP /UT ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$4,000
-20.0%
12,0000.0%0.00%0.0%
Q4 2019$5,000
+25.0%
12,0000.0%0.00%0.0%
Q3 2019$4,000
+33.3%
12,0000.0%0.00%
Q2 2019$3,000
-76.9%
12,0000.0%0.00%
-100.0%
Q1 2019$13,000
-38.1%
12,0000.0%0.00%
-33.3%
Q4 2018$21,00012,0000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$9,704,0004.11%
Ghost Tree Capital, LLC 219,977$1,790,0001.06%
JBF Capital, Inc. 148,178$1,205,0000.18%
Polar Capital LLP 900,604$7,326,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 80,000$651,0000.15%
HAMILTON LANE ADVISORS LLC 33,141$270,0000.11%
Jasper Ridge Partners, L.P. 63,996$521,0000.03%
Weiss Multi-Strategy Advisers LLC 95,000$773,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 550,000$4,474,0000.01%
AXA S.A. 292,625$2,381,0000.01%
View complete list of CONATUS PHARMACEUTICALS INC shareholders